598 related articles for article (PubMed ID: 31606236)
21. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
Bagchi S; Lingaiah R; Mani K; Barwad A; Singh G; Balooni V; Bhowmik D; Agarwal SK
PLoS One; 2019; 14(3):e0214256. PubMed ID: 30917188
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
[TBL] [Abstract][Full Text] [Related]
23. Markers for the progression of IgA nephropathy.
Maixnerova D; Reily C; Bian Q; Neprasova M; Novak J; Tesar V
J Nephrol; 2016 Aug; 29(4):535-41. PubMed ID: 27142988
[TBL] [Abstract][Full Text] [Related]
24. Serum Matrix Metalloproteinase-7 Level is Associated with Fibrosis and Renal Survival in Patients with IgA Nephropathy.
Zhang J; Ren P; Wang Y; Feng S; Wang C; Shen X; Weng C; Lang X; Chen Z; Jiang H; Chen J
Kidney Blood Press Res; 2017; 42(3):541-552. PubMed ID: 28922659
[TBL] [Abstract][Full Text] [Related]
25. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
26. An update on predicting renal progression in IgA nephropathy.
Barbour S; Reich H
Curr Opin Nephrol Hypertens; 2018 May; 27(3):214-220. PubMed ID: 29432215
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
Elíasdóttir S; Khramova A; Saeed A; Guron G; Boi R; Mölne J; Ebefors K; Nyström J
BMC Nephrol; 2023 Jun; 24(1):160. PubMed ID: 37286948
[TBL] [Abstract][Full Text] [Related]
28. Serum Phosphorus Might Be a Predictor of Kidney Disease Progression in IgA Nephropathy.
Li H; Lu W; Xie X; Wang Y; Dang X; Sun J; Jiang H
Kidney Blood Press Res; 2024; 49(1):20-26. PubMed ID: 38048756
[TBL] [Abstract][Full Text] [Related]
29. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.
Tanaka S; Ninomiya T; Masutani K; Nagata M; Tsuchimoto A; Tsuruya K; Kitazono T
Clin Exp Nephrol; 2015 Dec; 19(6):1062-70. PubMed ID: 25700934
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
[TBL] [Abstract][Full Text] [Related]
32. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 33741175
[TBL] [Abstract][Full Text] [Related]
33. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
Zhang J; Wang C; Tang Y; Peng H; Ye ZC; Li CC; Lou TQ
Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
Rauta V; Finne P; Fagerudd J; Rosenlöf K; Törnroth T; Grönhagen-Riska C
Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
[TBL] [Abstract][Full Text] [Related]
35. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
[TBL] [Abstract][Full Text] [Related]
36. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
Neuhaus J; Bauer F; Fitzner C; Hilgers RD; Seibert F; Babel N; Doevelaar A; Eitner F; Floege J; Rauen T; Westhoff TH
Kidney Blood Press Res; 2018; 43(5):1563-1572. PubMed ID: 30347407
[TBL] [Abstract][Full Text] [Related]
37. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
[TBL] [Abstract][Full Text] [Related]
38. Urinary CXCL1: a novel predictor of IgA nephropathy progression.
Zhao Y; Zhu L; Zhou T; Zhang Q; Shi S; Liu L; Lv J; Zhang H
PLoS One; 2015; 10(3):e0119033. PubMed ID: 25816025
[TBL] [Abstract][Full Text] [Related]
39. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
40. Pregnancy and Kidney Outcomes in Patients With IgA Nephropathy: A Cohort Study.
Su X; Lv J; Liu Y; Wang J; Ma X; Shi S; Liu L; Zhang H
Am J Kidney Dis; 2017 Aug; 70(2):262-269. PubMed ID: 28320554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
